s6y

Scilex Holding Co

Ticker
SCLX, SCLXW
CIK
1820190
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Scilex Holding Company/DE, Vickers Vantage Corp. I

Financials 32

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  7. 10-Q Quarterly Report for period ending Sep 30, 2025
  8. 10-Q Quarterly Report for period ending Jun 30, 2025
  9. 10-Q Quarterly Report for period ending Mar 31, 2025
  10. 10-K/A Annual Report for period ending Dec 31, 2024

All 32 financials filings

News 148

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 148 news filings

Ownership 114

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4/A Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 114 ownership filings

Prospectus 326

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-3 Registration statement for specified transactions by certain issuers
  3. S-3 Registration statement for specified transactions by certain issuers
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. RW Registration Withdrawal Request
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 326 prospectus filings

Proxies 15

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. PRER14A Preliminary revised proxy soliciting materials
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 15 proxies filings

Other 109

  1. SCHEDULE 13D/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. ARS Annual report to security holders
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 109 other filings